Zum Hauptinhalt springen
| Hans-Günter Meyer-Thompson | International

USA. Why an OASAS License for a Low-Threshold Bupe Provider Is So Significant

USA. Why an OASAS License for a Low-Threshold Bupe Provider Is So Significant

REACH—a harm reduction-oriented health center in Ithaca, New York that prescribes buprenorphine, among many other services—is about to get a license from the state’s Office of Addiction Services And Supports (OASAS).

This license to operate as an official outpatient treatment center is going to make it possible for founder and CEO Justine Waldman, MD and her team to continue their low-threshold model of treating opioid use disorder (OUD) on a far better financial footing than before, with the new ability to bill for their full range of services. (Filter, USA, 07.07.2020)

https://filtermag.org/oasas-low-threshold-buprenorphine-license/